Related Experiment Video
Updated: Sep 28, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Hypertension: Potential Player in Cardiovascular Disease Incidence in Preeclampsia
Parya Amini1, Mehran Amrovani2, Zohre Saleh Nassaj3
1Atherosclerosis Research Center, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.
Insights
Preeclampsia (PE) is a serious pregnancy complication affecting 3-7% of pregnancies and increasing cardiovascular disease (CVD) risk. Understanding blood pressure regulation pathways can lead to targeted therapies to reduce mortality in mothers with PE.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Research
- Molecular Biology
Background:
- Preeclampsia (PE) affects 3-7% of pregnancies, posing significant risks including preterm delivery and maternal mortality.
- Elevated blood pressure in PE is linked to increased cardiovascular disease (CVD) risk and mortality.
- Key factors regulating blood pressure include Atrial Natriuretic Peptide (ANP), the Renin-Angiotensin system, and nitric oxide (NO).
Purpose of the Study:
- To investigate the signaling pathways involved in blood pressure regulation by ANP, Renin-Angiotensin system, and NO in the context of preeclampsia.
- To identify potential therapeutic targets for managing hypertension in PE.
- To reduce the risk of CVD and mortality associated with preeclampsia.
Main Methods:
- Literature review of studies on preeclampsia pathophysiology.
- Analysis of molecular mechanisms underlying blood pressure regulation by ANP, Renin-Angiotensin system, and NO.
- Identification of signaling pathways implicated in PE-related hypertension.
Main Results:
- The study highlights the complex interplay of ANP, Renin-Angiotensin system, and NO in modulating blood pressure during pregnancy.
- Specific signaling pathways contributing to hypertension in PE were identified.
- These pathways represent potential targets for novel therapeutic interventions.
Conclusions:
- Targeted therapies focusing on identified signaling pathways can effectively reduce blood pressure in PE patients.
- Effective blood pressure management in PE can mitigate the long-term risk of cardiovascular disease.
- Further research into these pathways may lead to improved treatment strategies and reduced maternal mortality in preeclampsia.
Abstract:
Preeclampsia (PE) is one of the complications, that threatens pregnant mothers during pregnancy. According to studies, it accounts for 3-7% of all pregnancies, and also is effective in preterm delivery. PE is the third leading cause of death in pregnant women. High blood pressure in PE can increase the risk of developing cardiovascular disease (CVD) in cited individuals, and is one of the leading causes of death in PE individuals. Atrial natriuretic peptide (ANP), Renin-Angiotensin system and nitric oxide (NO) are some of involved factors in regulating blood pressure. Therefore, by identifying the signaling pathways, that are used by these molecules to regulate and modulate blood pressure, appropriate treatment strategies can be provided to reduce blood pressure through target therapy in PE individuals; consequently, it can reduce CVD risk and mortality.
More Related Videos
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hormonal Regulation
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension V: Nursing Management